Nesiritide
Links shared publicly online about this topic
Symposier - Nesiritide for Acute Heart Failure
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" Results from the 7,000-patient ASCEND-HF trial show that nesiritide was safe for treating patients with acute decompensated heart failure, but on average it only exerted a small dyspnea. Despite that, nesiritide has a role as a second-line agent because of its safety and ability to help certain patients. Read the story: http://bit.ly/evpUhy” View full resource at symposier.com
Most Recently Shared on December 3, 2010 at 11:48 pm By:
Nesiritide for Acute Heart Failure, Results from ASCENT-HF show nesiritide is safe. http://bit.ly/hZkpDY
NEJM: Should nesiritide be prescribed for HF at all?
cardiovascularbusiness.com — “While nesiritide (Natrecor, Johnson & Johnson) is approved by the FDA to treat dyspnea in acute heart failure (HF) patients, there is still an ongoing debate as to whether or not the human B-type natriuretic peptide is safe for the HF population. However, authors of the ASCEND-HF trial published in the July 7 issue of the New England Journal of Medicine concluded that they cannot recommend the drug’s use in the majority of acute HF patients due to its association with hypotension.” View full resource at cardiovascularbusiness.com
Most Recently Shared on July 18, 2011 at 8:10 pm By:
NEJM: Should nesiritide be prescribed for HF at all? http://bit.ly/mQEltp
Low-dose nesiritide with MI reperfusion therapy
theheart.org — “Given at much lower dosages than that used in acute heart failure, nesiritide given in a 72-hour infusion soon after MI reperfusion therapy seemed to improve LVEF at four weeks in a small, dose-finding "proof-of-concept" study.” View full resource at theheart.org
Most Recently Shared on August 12, 2009 at 4:38 pm By:
heartwire: Low-dose nesiritide explored as adjunct to MI reperfusion therapy http://bit.ly/1OeIj9
Nesiritide of no benefit in acute CHF | Hospital Medicine Quick Hits
blogs.hospitalmedicine.org — “Nesiritide of no benefit in acute CHF | Hospital Medicine Quick Hits” View full resource at blogs.hospitalmedicine.org
Most Recently Shared on July 9, 2011 at 9:20 pm By:
Nesiritide of no benefit in acute CHF: Nesiritide in recombinant BNP (that promotes vasodilation) which was FDA ... http://bit.ly/oHEaSE
ASCEND-HF: No Harm or Benefit with Nesiritide - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “With the publication of the final results of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial) in the New England Journal of Medicine, the once intense controversy over the use-- or misuse-- of the drug nesiritide in patients with acute decompensated heart failure has [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 7, 2011 at 3:56 pm By:
ASCEND-HF: No Harm or Benefit with Nesiritide: With the publication of the final results of the ASCEND-... http://onforb.es/p9usJq #drug
Heart Failure Study Debunks Findings on Nesiritide - NYTimes.com
nytimes.com — “A large study shows that nesiritide, which a smaller study had suggested had great promise, does not seem to be particularly effective.” View full resource at nytimes.com
Most Recently Shared on November 15, 2010 at 8:03 pm By:
Heart Failure Study Debunks Findings on Nesiritide - NYTimes.com
nytimes.com — “A large study shows that nesiritide, which a smaller study had suggested had great promise, does not seem to be particularly effective.” View full resource at nytimes.com
Most Recently Shared on November 16, 2010 at 12:00 am By:
Heart Failure Study Debunks Findings on Nesiritide - NYTimes.com
nytimes.com — “A large study shows that nesiritide, which a smaller study had suggested had great promise, does not seem to be particularly effective.” View full resource at nytimes.com
Most Recently Shared on November 15, 2010 at 8:11 pm By:
small studies of heart failure drug were wrong, it seems, http://www.nytimes.com/2010/11/16/health/16heart.html?hp
Industry-Funded Study: Nesiritide 'Cannot Be Recommended for Routine Use' in Acute Heart Failure - Physician's First Watch
firstwatch.jwatch.org — “Nesiritide "cannot be recommended for routine use in the broad population of patients with acute heart failure," according to a manufacturer-funded study published in the New England Journal of Medicine. (These results were first . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on July 11, 2011 at 6:35 pm By:
Nesiritide 'Cannot Be Recommended for Routine Use' in Acute Heart Failure http://t.co/crQkCy4
Caution Advised in Nesiritide Use in Patients with Decompensated Diastolic HF with Right Ventricular Failure - ONA
oncologynurseadvisor.com — “Nesiritide has been demonstrated to improve symptoms and hemodynamics in patients with left ventricular failure (LVF). This data was presented at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 3, 2011 at 6:30 pm By:
Caution Advised in Nesiritide Use in Patients with Decompensated Diastolic HF with Right… http://goo.gl/fb/k4kAP
US joins suit against Scios
theheart.org — “News and education programs about Heart Failure from Heartwire news and renowned specialists. Get CME educational programs free. Improved Patient Care N-HeFT.” View full resource at theheart.org
Most Recently Shared on February 19, 2009 at 11:07 pm By:
US joins suit against Scios alleging nesiritide promotion for off-label use http://tinyurl.com/da43ug
Ineffective Drug Shows Flawed Test Process - Drugs.com MedNews
drugs.com — “Ineffective Drug Shows Flawed Test Process The News Observer, Raleigh, N.C. From News Observer (Raleigh, NC) (November 15, 2010) A controversial drug used to tr” View full resource at drugs.com
Most Recently Shared on November 15, 2010 at 3:10 pm By:
Ineffective Drug Shows Flawed Test Process: Ineffective Drug Shows Flawed Test Process [The News & Observe... http://bit.ly/9C887q #drug
Natrecor for acute decompensated HF | theheart.org
theheart.org — “News and education programs about Heart Failure from Heartwire news and renowned specialists. Get CME educational programs free. Improved Patient Care N-HeFT.” View full resource at theheart.org
Most Recently Shared on November 14, 2010 at 11:05 pm By:
ASCEND-HF: Nesiritide safe but of limited dyspnea benefit in acute HF: Five years ago, one of the biggest, most ... http://bit.ly/bXjsZZ
Scios Announces Results Of ASCEND Heart Failure Study At The Scientific Sessions Of The American Heart Association
medicalnewstoday.com — “Scios Inc. announced that the landmark investigational study of NATRECOR® (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically” View full resource at medicalnewstoday.com
Most Recently Shared on November 16, 2010 at 12:40 pm By:
Scios Announces Results Of ASCEND Heart Failure Study At The Scientific Sessions Of The American Heart Association http://mnt.to/3MCg
Emergency Medicine Article | Heart Failure
mdlinx.com — “Effect of Nesiritide in Patients with Acute Decompensated Heart Failure” View full resource at mdlinx.com
Most Recently Shared on July 13, 2011 at 11:00 am By:
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure: New England Journal of Medicine http://bit.ly/qDONKG #ER
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Tammi Jacobs
Competent, fun, well designed diet & workout to allow you control to Empower You. Inspiring Women Entrepreneurs Social Media Fan. Find me: http://bit.ly/Get_Fit
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement

